Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBiohaven Non-GAAP EPS of -$0.98N/A
2023-03-24 07:34 ESTNewsBiohaven Non-GAAP EPS of -$1.27 beats by $0.01N/A
2023-03-22 08:38 ESTNewsBiohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfrontN/A
2023-03-10 05:36 ESTNewsBiohaven: Spun And Done - Time To ExitN/A
2023-02-21 22:11 ESTNewsBiohaven's spinal muscular atrophy therapy gets FDA fast track statusN/A
2023-01-04 17:02 ESTNewsBiohaven initiated at overweight at JP Morgan on neurological targetsN/A
2022-12-08 04:49 ESTNewsBiohaven Ltd: Assessing The SpinoffN/A
2022-11-09 21:19 ESTNewsBiohaven Non-GAAP EPS of -$1.25N/A
2022-10-21 04:41 ESTNewsBiohaven prices upsized 25M of stock offering at $10.50/shareN/A
2022-10-18 16:23 ESTNewsBiohaven stock falls 5% after the bell on 20M share offeringN/A
2022-10-07 13:52 ESTNewsBiotech in recovery; but Piper Sandler cites negative fund flowsN/A
2022-10-07 13:49 ESTNewsM&A may be a tailwind for biotech sector into end of year, analyst saysN/A
2022-10-07 13:40 ESTNews'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potentialN/A
2022-10-06 23:49 ESTNewsBiohaven Stub May Provide An Interesting Setup For InvestorsN/A
2022-09-29 23:19 ESTNewsBiohaven says ALS candidate failed in key trialN/A
2022-09-28 00:37 ESTNewsPfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3N/A
2022-09-19 19:50 ESTNewsBiohaven announces timeline for spinoffN/A
2022-08-17 15:12 ESTNewsBiohaven: Non-Standard Merger Consideration Makes This A BuyN/A
2022-08-16 05:06 ESTNewsSoros Fund Management takes new stakes in GCP, Biohaven, TeslaN/A
2022-08-05 15:33 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6MN/A
2022-07-07 09:59 ESTNewsBiohaven begins enrolling in late-stage trial of spinal muscular atrophy therapyN/A
2022-06-15 23:08 ESTNewsBiohaven Deal: Pfizer Gives Away A FreerollN/A
2022-06-01 11:56 ESTNewsFederal Trade Commission to hold pharma merger and antitrust workshopN/A
2022-05-23 14:53 ESTNewsBiohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progressionN/A
2022-05-23 14:53 ESTNewsBiohaven gets FDA review for nasal spray zavegepant to treat migraineN/A
2022-05-11 01:00 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14MN/A
2022-05-11 01:00 ESTNewsPfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%N/A
2022-05-06 21:00 ESTNewsBiohaven Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-27 19:21 ESTNewsPfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraineN/A
2022-04-14 05:28 ESTNewsBiohaven Pharmaceutical: Recent Growth Will ContinueN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47MN/A
2022-02-26 00:18 ESTNewsBiohaven in licensing pact with Bristol Myers; to acquire Channel BiosciencesN/A
2022-02-26 00:18 ESTNewsPfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatmentN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-26 00:17 ESTNewsBiohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 05:15 ESTNewsBiohaven Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-22 19:32 ESTNewsBiohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitisN/A
2022-02-15 01:21 ESTNewsPfizer/ Biohaven announce late-stage migraine trial met main goals in Asia PacificN/A
2022-02-01 23:30 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-28 21:24 ESTNewsAurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen newsN/A
2022-01-18 18:11 ESTNewsBiohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapiesN/A
2022-01-14 05:01 ESTNewsAurinia Pharmaceuticals reverses decline after report on potential M&A interestN/A
2022-01-10 16:33 ESTNewsBiohaven forms research collaboration to advance TRPM3 antagonists for pain managementN/A
2022-01-06 09:41 ESTNewsBiohaven reports preliminary Q4 Nurtec ODT revenue of $190MN/A
2021-12-07 06:52 ESTNewsBiohaven names Vlad Coric as Chairman, appoints new CFON/A
2021-12-06 12:13 ESTNewsBiohaven says pivotal study for intranasal migraine therapy met main goalsN/A
2021-12-06 12:13 ESTNewsBiohaven names new CEO, CFON/A
2021-11-18 11:13 ESTNewsBiohaven, Artizan to work on Parkinson's drug discovery programN/A
2021-11-17 13:22 ESTNewsBiohaven's migraine med Nurtec approved in KuwaitN/A
2021-11-10 03:44 ESTNewsPfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B dealN/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

See Advanced Chart

General

  • Name Biohaven Pharmaceutical Holding Company Ltd
  • Symbol BHVN
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 825
  • Fiscal Year EndDecember
  • IPO Date2017-05-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biohavenpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 71.25
  • Price/Book (Most Recent Quarter) 31.82
  • Enterprise Value Revenue 73.75
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$10.49
  • Next Year EPS Estimate -$5.57
  • Next Quarter EPS Estimate -$2.73
  • Operating Margin -1014%
  • Return on Assets -78%
  • Revenue 63.63 million
  • Earnings Per Share -$9.14
  • Revenue Per Share $1.08
  • Gross Profit 45.93 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 4.42 billion
  • EBITDA -356321504
  • Analyst Target Price $102.09
  • Book Value Per Share $2.09
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 54.37 million
  • % Held by Insiders 1379%
  • % Held by Institutions 117.55%
  • Shares Short 5.76 million
  • Shares Short Prior Month 5.98 million
  • Short Ratio 11.39
  • Short % of Float 13%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.08
  • 52 Week High $100.77
  • 52 Week Low $28.26
  • 50 Day Moving Average 82.8
  • 200 Day Moving Average 80.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$2.69-$2.56-4.98%
2020-09-302020-11-09$17.66 million-$2.67-$2.866.58%
2020-06-302020-08-10$9.7 million-$2.55-$2.8410.27%
2020-03-312020-05-07$1.15 million-$2.39-$2.462.94%
2019-12-312020-02-25$N/A-$2.85-$1.91-49.31%
2019-09-302019-11-01$N/A-$2.04-$1.57-30.24%
2019-06-302019-08-08$N/A-$4.67-$2.09-123.21%
2019-03-312019-05-07$N/A-$1.41-$1.505.94%
2018-12-312019-02-28$N/A-$1.33-$1.21-10.12%
2018-09-302018-11-14$N/A-$1.53-$1.08-42.33%
2018-06-302018-08-14$N/A-$1.01-$1.053.68%
2018-03-312018-05-15$N/A-$2.32-$1.17-98.29%
2017-12-312018-03-06$N/A-$0.75-$1.3544.34%
2017-09-302017-11-14$N/A-$1.19-$1.243.78%
2017-06-302017-08-14$N/A-$1.78-$0.62-185.94%
2017-03-312017-06-16$N/A-$1.74-$1.45-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-17115.4CALL2 61019.64TRUE1.30.09
2026-07-172.513.85CALL4 5559.91TRUE1.10.09
2026-07-17412.45CALL2 3577.47TRUE1.390.13
2026-07-17511.45CALL2 9320.97TRUE1.350.13
2026-07-17610.35CALL2 37273.12TRUE1.650.19
2026-07-177.58.9CALL2 6181.36TRUE1.150.15
2026-07-1797.16CALL2 17168.12TRUE1.050.17
2026-07-17105.7CALL0 306115.72TRUE00
2026-07-17115.19CALL2 5199142.13TRUE0.490.1
2026-07-1712.53.77CALL16 2618111.18TRUE0.420.13
2026-07-17142.38CALL40 92375.53TRUE2.380
2026-07-17151.65CALL16 602591.47TRUE0.350.27
2026-07-17161CALL127 70782.03FALSE-0.15-0.13
2026-07-1717.50.5CALL19 540185.39FALSE00
2026-07-17190.4CALL6 7490.97FALSE0.120.43
2026-07-17200CALL0 82390.47FALSE00
2026-07-17210CALL0 308146.68FALSE00
2026-07-17220CALL0 0155.44FALSE00
2026-07-17230CALL0 0168.4FALSE00
2026-07-17240CALL0 0180.45FALSE00
2026-07-17250CALL0 0178.91FALSE00
2026-07-17260CALL0 1202.31FALSE00
2026-07-17300CALL0 0228.71FALSE00
2026-07-1710PUT0 1637.5FALSE00
2026-07-172.50PUT0 0417.74FALSE00
2026-07-1740PUT0 0313.01FALSE00
2026-07-1750PUT0 2264.53FALSE00
2026-07-1760PUT0 6225.3FALSE00
2026-07-177.50PUT0 151177.52FALSE00
2026-07-1790PUT0 135186.33FALSE00
2026-07-17100PUT0 448212.3FALSE00
2026-07-17110PUT0 2162136.76FALSE00
2026-07-1712.50.21PUT0 143107.66FALSE00
2026-07-17140PUT0 7793.01FALSE00
2026-07-17151.05PUT0 159100.49FALSE00
2026-07-17160PUT0 10480.65TRUE00
2026-07-1717.50PUT0 098.63TRUE00
2026-07-17190PUT0 0104.92TRUE00
2026-07-17200PUT0 1116.4TRUE00
2026-07-17210PUT0 1142.5TRUE00
2026-07-17227.35PUT0 0117.25TRUE00
2026-07-17238.4PUT0 2119.21TRUE00
2026-07-17240PUT0 2116.99TRUE00
2026-07-17250PUT0 1180.65TRUE00
2026-07-172611.3PUT0 0168.15TRUE00
2026-07-173015.25PUT0 0139.55TRUE00
2026-08-21412.46CALL2 2255.7TRUE1.010.09
2026-08-21511.4CALL2 1215.47TRUE0.90.09
2026-08-2160CALL0 1183.45TRUE00
2026-08-2170CALL0 1181.24TRUE00
2026-08-2180CALL0 0162.05TRUE00
2026-08-2190CALL0 0139.01TRUE00
2026-08-21100CALL0 11140.91TRUE00
2026-08-21115.1CALL0 50137.86TRUE00
2026-08-21123.83CALL0 220103.63TRUE00
2026-08-21133.65CALL0 40099.32TRUE00
2026-08-21140CALL0 0104.72TRUE00
2026-08-21152.55CALL1 2776.28TRUE2.550
2026-08-21160CALL0 2483.37FALSE00
2026-08-21171.49CALL1 1273.86FALSE-0.01-0.01
2026-08-21181.27CALL44 4284.73FALSE0.270.27
2026-08-21191.17CALL10 1582.18FALSE1.170
2026-08-21200CALL0 8196.07FALSE00
2026-08-21210CALL0 20122.92FALSE00
2026-08-21220CALL0 0129.52FALSE00
2026-08-21230CALL0 0128.14FALSE00
2026-08-21240CALL0 0130.58FALSE00
2026-08-21250CALL0 0106.13FALSE00
2026-08-21260CALL0 0115.27FALSE00
2026-08-21270CALL0 0122.49FALSE00
2026-08-21280CALL0 0127.8FALSE00
2026-08-21290CALL0 0148.45FALSE00
2026-08-21300CALL0 0137.64FALSE00
2026-08-2140PUT0 0315.15FALSE00
2026-08-2150PUT0 0266.95FALSE00
2026-08-2160PUT0 0229.04FALSE00
2026-08-2170PUT0 0197.73FALSE00
2026-08-2180PUT0 0170.98FALSE00
2026-08-2190PUT0 0147.5FALSE00
2026-08-21100PUT0 0135.36FALSE00
2026-08-21110PUT0 12140.57FALSE00
2026-08-21120PUT0 279.83FALSE00
2026-08-21130PUT0 5196.42FALSE00
2026-08-21140PUT0 081.17FALSE00
2026-08-21150PUT0 173.18FALSE00
2026-08-21160PUT0 399.97TRUE00
2026-08-21170PUT0 078.66TRUE00
2026-08-21180PUT0 0104.75TRUE00
2026-08-21190PUT0 064.89TRUE00
2026-08-21200PUT0 044.37TRUE00
2026-08-21210PUT0 088.99TRUE00
2026-08-21220PUT0 0112.86TRUE00
2026-08-21230PUT0 0104.94TRUE00
2026-08-21240PUT0 0103.04TRUE00
2026-08-21250PUT0 095.29TRUE00
2026-08-21260PUT0 0125.01TRUE00
2026-08-21270PUT0 091.74TRUE00
2026-08-21280PUT0 1102.24TRUE00
2026-08-21290PUT0 0106.96TRUE00
2026-08-21300PUT0 0111.48TRUE00
2026-10-1630CALL0 1181.78TRUE00
2026-10-1640CALL0 0130.54TRUE00
2026-10-1650CALL0 0134.39TRUE00
2026-10-1660CALL0 0158.28TRUE00
2026-10-1670CALL0 21148.72TRUE00
2026-10-1680CALL0 32138.85TRUE00
2026-10-1690CALL0 51131.84TRUE00
2026-10-16100CALL0 119124.09TRUE00
2026-10-16110CALL0 235120.31TRUE00
2026-10-16125.5CALL1 1012103.24TRUE5.50
2026-10-16130CALL0 122109.26TRUE00
2026-10-16140CALL0 126110.87TRUE00
2026-10-16153.62CALL14 20791.8TRUE0.570.19
2026-10-16162.69CALL0 5992.69FALSE00
2026-10-16172.8CALL9 21892.84FALSE0.150.06
2026-10-16180CALL0 68110.71FALSE00
2026-10-16191.9CALL0 50105.48FALSE00
2026-10-16200CALL0 1141103.75FALSE00
2026-10-16210CALL0 586.76FALSE00
2026-10-16220CALL0 0105.97FALSE00
2026-10-16230CALL0 0107.99FALSE00
2026-10-16240CALL0 0111.82FALSE00
2026-10-16250.75CALL0 594.63FALSE00
2026-10-16260CALL0 10100.84FALSE00
2026-10-16300CALL0 0116.37FALSE00
2026-10-1630PUT0 0187.09FALSE00
2026-10-1640PUT0 0202.55FALSE00
2026-10-1650PUT0 1226.93FALSE00
2026-10-1660PUT0 6215.63FALSE00
2026-10-1670PUT0 4168.82FALSE00
2026-10-1680PUT0 1120.1FALSE00
2026-10-1690PUT0 140120.05FALSE00
2026-10-16100PUT0 147122.19FALSE00
2026-10-16110PUT0 120133.29FALSE00
2026-10-16120PUT0 1104.53FALSE00
2026-10-16130PUT0 6117.04FALSE00
2026-10-16140PUT0 083.15FALSE00
2026-10-16150PUT0 10595.98FALSE00
2026-10-16160PUT0 793.9TRUE00
2026-10-16170PUT0 280.27TRUE00
2026-10-16180PUT0 097.66TRUE00
2026-10-16190PUT0 097.03TRUE00
2026-10-16200PUT0 082.65TRUE00
2026-10-16210PUT0 098.77TRUE00
2026-10-16220PUT0 094.51TRUE00
2026-10-16230PUT0 0108.23TRUE00
2026-10-16240PUT0 097.73TRUE00
2026-10-16250PUT0 0106.12TRUE00
2026-10-16260PUT0 091.15TRUE00
2026-10-16300PUT0 093.32TRUE00
2026-12-182.50CALL0 35138.45TRUE00
2026-12-1850CALL0 3090.28TRUE00
2026-12-1860CALL0 0118.65TRUE00
2026-12-187.59.41CALL10 80110.28TRUE9.410
2026-12-1890CALL0 15129.3TRUE00
2026-12-18100CALL0 257104.64TRUE00
2026-12-18110CALL0 9112.95TRUE00
2026-12-1812.50CALL0 14696.73TRUE00
2026-12-18140CALL0 0101.47TRUE00
2026-12-18155.2CALL10 661112.33TRUE0.70.16
2026-12-18165.1CALL106 773112.77FALSE0.60.13
2026-12-1817.50CALL0 49105.48FALSE00
2026-12-18203.67CALL3 750109.16FALSE0.280.08
2026-12-1822.50CALL0 3291.56FALSE00
2026-12-18252.5CALL8 47108.2FALSE2.50
2026-12-1827.50CALL0 0113.14FALSE00
2026-12-18300CALL0 13126.5FALSE00
2026-12-1832.50CALL0 1100.37FALSE00
2026-12-18351.27CALL1 62101.74FALSE1.270
2026-12-1837.50CALL0 097.86FALSE00
2026-12-18400CALL0 4112.6FALSE00
2026-12-1842.50CALL0 1105.87FALSE00
2026-12-18450CALL0 37103.89FALSE00
2026-12-1847.50CALL0 2105.32FALSE00
2026-12-18500CALL0 11106.36FALSE00
2026-12-1852.50CALL0 9108.25FALSE00
2026-12-18550CALL0 2109.9FALSE00
2026-12-1857.50CALL0 0111.33FALSE00
2026-12-18600CALL0 15113.9FALSE00
2026-12-18650CALL0 38115.85FALSE00
2026-12-182.50PUT0 65157.84FALSE00
2026-12-1850PUT0 3136.61FALSE00
2026-12-1860PUT0 0102.5FALSE00
2026-12-187.50PUT0 222113.85FALSE00
2026-12-1890PUT0 107100.6FALSE00
2026-12-18100PUT0 277104.53FALSE00
2026-12-18110PUT0 6107.32FALSE00
2026-12-1812.52.46PUT1 266111.94FALSE2.460
2026-12-18140PUT0 696.18FALSE00
2026-12-18150PUT0 20991.58FALSE00
2026-12-18160PUT0 0107.85TRUE00
2026-12-1817.50PUT0 54111.95TRUE00
2026-12-18200PUT0 100104.48TRUE00
2026-12-1822.50PUT0 22111.31TRUE00
2026-12-18250PUT0 8109.82TRUE00
2026-12-1827.50PUT0 0109.82TRUE00
2026-12-18300PUT0 330113.18TRUE00
2026-12-1832.50PUT0 0109.86TRUE00
2026-12-18350PUT0 0107.66TRUE00
2026-12-1837.50PUT0 0110.34TRUE00
2026-12-18400PUT0 0110.63TRUE00
2026-12-1842.50PUT0 0105.76TRUE00
2026-12-18450PUT0 0110.29TRUE00
2026-12-1847.50PUT0 0109.74TRUE00
2026-12-18500PUT0 0113.7TRUE00
2026-12-1852.50PUT0 0111.78TRUE00
2026-12-18550PUT0 0107.53TRUE00
2026-12-1857.50PUT0 0115.03TRUE00
2026-12-18600PUT0 0114.02TRUE00
2026-12-18650PUT0 00TRUE00
2027-01-1510CALL0 0211.04TRUE00
2027-01-152.50CALL0 55124.59TRUE00
2027-01-1540CALL0 0128.67TRUE00
2027-01-1550CALL0 66118.32TRUE00
2027-01-1560CALL0 0137.49TRUE00
2027-01-157.58.57CALL0 75109.48TRUE00
2027-01-1590CALL0 17117.05TRUE00
2027-01-15108CALL11 1102112.35TRUE0.80.11
2027-01-15110CALL0 4115.1TRUE00
2027-01-1512.50CALL0 1265115.49TRUE00
2027-01-15140CALL0 9113.69TRUE00
2027-01-15155.6CALL1 4969114.49TRUE0.390.07
2027-01-15160CALL0 91124.03FALSE00
2027-01-1517.54.26CALL0 154108.4FALSE00
2027-01-15204CALL10 100112.6FALSE0.50.14
2027-01-1522.50CALL0 5116.71FALSE00
2027-01-15252.8CALL5 156108.59FALSE2.80
2027-01-1527.50CALL0 332120.4FALSE00
2027-01-15301.81CALL0 3976107.86FALSE00
2027-01-1532.50CALL0 8113.72FALSE00
2027-01-15350CALL0 5114.72FALSE00
2027-01-1537.50CALL0 5103.82FALSE00
2027-01-15400CALL0 106106.23FALSE00
2027-01-1542.50CALL0 52126.43FALSE00
2027-01-15450CALL0 8104.07FALSE00
2027-01-1547.50CALL0 0105.79FALSE00
2027-01-15500CALL0 11104.41FALSE00
2027-01-1552.50CALL0 0101.18FALSE00
2027-01-15550CALL0 199.17FALSE00
2027-01-1557.50CALL0 51100.38FALSE00
2027-01-15600CALL0 8104.04FALSE00
2027-01-15650CALL0 11108.45FALSE00
2027-01-1510PUT0 0198.27FALSE00
2027-01-152.50PUT0 24146.45FALSE00
2027-01-1540PUT0 4182.34FALSE00
2027-01-1550PUT0 110126.84FALSE00
2027-01-1560.5PUT0 40157.88FALSE00
2027-01-157.50PUT0 73122.88FALSE00
2027-01-1590PUT0 16108.35FALSE00
2027-01-15101.7PUT1 187129.01FALSE-0.2-0.11
2027-01-15112.15PUT1 4144.99FALSE-0.15-0.07
2027-01-1512.53.1PUT0 104119.52FALSE00
2027-01-15143.8PUT2 2117.35FALSE-0.2-0.05
2027-01-15154.3PUT1 330122.67FALSE4.30
2027-01-15165PUT1 151122.78TRUE50
2027-01-1517.50PUT0 12129.33TRUE00
2027-01-15200PUT0 114112.68TRUE00
2027-01-1522.50PUT0 3120.14TRUE00
2027-01-15250PUT0 8124.46TRUE00
2027-01-1527.50PUT0 0117.44TRUE00
2027-01-15300PUT0 4108.48TRUE00
2027-01-1532.50PUT0 0108.28TRUE00
2027-01-15350PUT0 0105.49TRUE00
2027-01-1537.50PUT0 0105.43TRUE00
2027-01-15400PUT0 0101.01TRUE00
2027-01-1542.50PUT0 0103.89TRUE00
2027-01-15450PUT0 0102.27TRUE00
2027-01-1547.50PUT0 0101.6TRUE00
2027-01-15500PUT0 0107.78TRUE00
2027-01-1552.50PUT0 0106.12TRUE00
2027-01-15550PUT0 096.4TRUE00
2027-01-1557.50PUT0 00TRUE00
2027-01-15600PUT0 0115.72TRUE00
2027-01-15650PUT0 0121.46TRUE00
2028-01-212.50CALL0 482123.19TRUE00
2028-01-2150CALL0 12396.21TRUE00
2028-01-217.50CALL0 493100.38TRUE00
2028-01-21108.97CALL15 175488.26TRUE8.970
2028-01-2112.50CALL0 9994.75TRUE00
2028-01-21157.25CALL0 131793.16TRUE00
2028-01-2117.50CALL0 17102.73FALSE00
2028-01-21205.82CALL22 138997.13FALSE5.820
2028-01-2122.50CALL0 793.17FALSE00
2028-01-21250CALL0 5589.32FALSE00
2028-01-2127.50CALL0 2884.93FALSE00
2028-01-21300CALL0 102376.82FALSE00
2028-01-2132.50CALL0 083.96FALSE00
2028-01-21350CALL0 13481.14FALSE00
2028-01-212.50PUT0 11108.05FALSE00
2028-01-2150PUT0 2112.32FALSE00
2028-01-217.50PUT0 8117.82FALSE00
2028-01-21100PUT0 82695.61FALSE00
2028-01-2112.50PUT0 2297.55FALSE00
2028-01-21150PUT0 2495.76FALSE00
2028-01-2117.50PUT0 192.51TRUE00
2028-01-21200PUT0 191.68TRUE00
2028-01-2122.50PUT0 089.77TRUE00
2028-01-21250PUT0 290.23TRUE00
2028-01-2127.50PUT0 086.69TRUE00
2028-01-21300PUT0 185.6TRUE00
2028-01-2132.50PUT0 087.16TRUE00
2028-01-21350PUT0 2484.92TRUE00

Latest BHVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST40$143.84
Jun 13, 2022 7:59 PM EST9$143.84
Jun 13, 2022 7:59 PM EST8$143.87
Jun 13, 2022 7:59 PM EST100$143.87
Jun 13, 2022 7:59 PM EST3$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-15Elyse StockChief Medical OfficerSell800.0045.0136,008.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18Elyse StockChief Medical OfficerSell17,700.0045.07797,749.620.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04ERIC AGUIARDirectorSell17,609.0042.54749,086.860.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorSell10,000.0045.00450,000.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20ERIC AGUIARDirectorSell6,729.0052.20351,234.290.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22ERIC AGUIARDirectorSell1,250.0055.2469,050.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09ERIC AGUIARDirectorSell4,072.0055.11224,410.770.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16ERIC AGUIARDirectorSell3,537.0055.13194,984.550.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10John TiltonChief Commercial OfficerSell10,500.0037.67395,535.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12John TiltonChief Commercial OfficerSell10,000.0050.11501,100.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21JULIA P GREGORYDirectorSell12,000.0043.56522,720.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorSell12,000.0054.75656,956.800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsSell3,935.0053.03208,665.180.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsSell21,065.0053.041,117,205.450.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09ERIC AGUIARDirectorSell30,000.0056.391,691,700.000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12John TiltonChief Commercial OfficerBuy10,000.009.2992,900.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26JOHN W CHILDSDirectorBuy10,000.0040.37403,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26Declan DooganDirectorSell5,824.0053.72312,865.281,014,827.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22Declan DooganDirectorSell5,351.0053.66287,134.661,020,651.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01Declan DooganDirectorSell50,000.0047.192,359,500.001,026,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10John TiltonChief Commercial OfficerBuy10,500.009.2997,545.0010,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22JOHN W CHILDSDirectorBuy107,500.009.29998,675.00107,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01Declan DooganDirectorSell595.0045.4127,018.951,076,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27Declan DooganDirectorSell23,384.0045.711,068,882.641,076,597.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Vlad CoricChief Executive OfficerBuy10,950.0010,950.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25Declan DooganDirectorSell13,943.0045.49634,267.071,099,981.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19Declan DooganDirectorSell1,400.0045.5163,714.001,113,924.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15Declan DooganDirectorSell678.0045.4230,794.761,115,324.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13Declan DooganDirectorSell6,158.0044.24272,429.921,116,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12Declan DooganDirectorSell33,842.0044.321,499,877.441,122,160.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03Declan DooganDirectorSell40,000.0041.951,678,000.001,156,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18John TiltonCCO-Rare & Neurologic DisorderBuy1,250.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08ERIC AGUIARDirectorBuy1,250.0055.9169,887.501,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22ERIC AGUIARDirectorSell150.0058.868,828.601,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtBuy125,000.000.6176,250.00125,341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12Elyse StockChief Medical OfficerSell15,925.0064.891,033,347.7713,234.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtBuy986.000.61601.461,327.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11James EngelhartChief Financial OfficerSell4,847.0063.19306,286.2913,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell200.0058.0011,599.001,400.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy11,453.009.29106,398.3715,975.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell671.0056.9938,243.181,600.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell59,914.0075.254,508,822.081,741.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell1,300.0077.70101,005.061,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04ERIC AGUIARDirectorBuy7,609.0020.79158,191.1117,609.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18Elyse StockChief Medical OfficerBuy17,700.0010.82191,514.0017,700.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11James EngelhartChief Financial OfficerSell5,972.0062.07370,697.5718,322.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12Elyse StockChief Medical OfficerSell11,390.0065.80749,497.311,844.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26Vlad CoricChief Executive OfficerBuy5,000.0040.22201,100.0019,130.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22ERIC AGUIARDirectorBuy771.0032.4224,995.822,021.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsBuy21,065.000.6112,849.6521,065.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell5,261.0075.62397,843.6621,878.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy20,716.0020.79430,685.6422,560.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0055.9927,995.502,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27Robert BermanChief Medical OfficerBuy2,500.0042.30105,750.00240,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11James EngelhartChief Financial OfficerBuy19,772.009.29183,681.8824,294.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07JOHN W CHILDSDirectorSell14,734.0033.26490,119.142,476,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11JOHN W CHILDSDirectorBuy2,600.0060.32156,823.942,479,538.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11JOHN W CHILDSDirectorBuy7,271.0061.28445,567.612,486,809.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07JOHN W CHILDSDirectorSell93,268.0032.923,070,130.742,491,672.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27James EngelhartChief Financial OfficerBuy2,500.0043.05107,625.002,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11JOHN W CHILDSDirectorBuy15,129.0061.87936,093.262,501,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11JOHN W CHILDSDirectorBuy6,678.0059.00393,983.972,508,616.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21JOHN W CHILDSDirectorBuy3,322.0059.25196,828.502,511,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23Gregory BaileyDirectorSell212.0079.9416,948.002,545,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23Gregory BaileyDirectorSell10,191.0078.89803,918.052,545,870.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell3,100.0079.88247,632.032,556,061.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell21,466.0079.411,704,720.242,559,161.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19Gregory BaileyDirectorSell4,554.0078.98359,655.342,580,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25Gregory BaileyDirectorBuy107,500.009.29998,675.002,582,601.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07JOHN W CHILDSDirectorSell10,908.0031.55344,196.492,584,940.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16Gregory BaileyDirectorSell3,748.0078.88295,638.122,585,181.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20Gregory BaileyDirectorBuy5,000.0037.65188,250.002,587,601.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12Gregory BaileyDirectorSell6,729.0078.87530,740.452,588,929.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08Gregory BaileyDirectorSell5,991.0075.93454,888.242,595,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07JOHN W CHILDSDirectorSell81,090.0030.542,476,585.912,595,848.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08Gregory BaileyDirectorSell44,009.0075.123,305,876.862,601,649.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24Gregory BaileyDirectorSell2,395.0070.24168,224.802,645,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24Gregory BaileyDirectorSell1,600.0069.29110,864.962,648,053.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell835.0075.1862,779.312,649,653.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell63,257.0074.604,719,256.862,650,488.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06JOHN W CHILDSDirectorSell5,341.0031.76169,626.962,676,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06JOHN W CHILDSDirectorSell144,659.0031.234,517,309.992,682,279.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23Gregory BaileyDirectorSell24,084.0073.721,775,368.922,713,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsBuy23,500.009.29218,315.0027,139.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23Gregory BaileyDirectorSell13,467.0072.70979,026.662,737,829.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22Gregory BaileyDirectorSell49,132.0073.643,618,011.702,751,296.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy24,000.005.60134,400.0027,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0054.9727,485.852,771.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05Gregory BaileyDirectorBuy212,500.000.61129,625.002,800,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22Gregory BaileyDirectorSell20,659.0072.911,506,202.242,800,428.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22Gregory BaileyDirectorSell10,540.0072.01758,961.162,821,087.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell428.0075.2232,193.392,831,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell22,584.0073.781,666,267.852,832,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell12,157.0072.93886,618.522,854,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell21,798.0071.981,568,935.032,866,796.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell58,238.0070.914,129,854.592,888,594.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12Elyse StockChief Medical OfficerSell5,300.0064.05339,448.0429,159.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Gregory BaileyDirectorSell26,814.0070.101,879,792.792,946,832.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy150,000.005.60840,000.002,950,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10James EngelhartChief Financial OfficerSell28,821.0066.661,921,135.8129,654.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19Gregory BaileyDirectorSell22,012.0069.011,519,094.352,973,646.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy37,700.009.29350,233.002,987,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09ERIC AGUIARDirectorBuy30,000.009.29278,700.0030,000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05Gregory BaileyDirectorBuy20,000.0010.82216,400.003,007,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05Gregory BaileyDirectorBuy18,000.0028.76517,680.003,025,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy1,000.0037.5437,540.003,049.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell4,010.0077.01308,799.273,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell55,626.0075.254,185,745.253,119.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10John TiltonChief Commercial OfficerSell21,364.0066.701,425,036.4831,406.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy30,000.0050.721,521,600.0031,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10John TiltonChief Commercial OfficerSell5,331.0068.57365,528.013,237.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.003,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy17,500.000.6110,675.0033,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Elyse StockChief Medical OfficerBuy3,375.003,375.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell300.0055.9716,791.00341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell1,400.0076.05106,467.48341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtSell986.0075.0774,015.96341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtSell4,296.0075.05322,431.12341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell2,778.0075.29209,144.51341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12Elyse StockChief Medical OfficerSell4,351.0063.02274,208.7234,459.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16ERIC AGUIARDirectorBuy3,537.0020.7973,534.233,537.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy590.0020.7912,266.103,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsSell600.0070.0542,027.483,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsSell24,000.0070.201,684,869.603,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell2,458.0077.42190,300.083,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy36,314.000.6122,151.5436,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27Declan DooganDirectorSell1,900.0045.8687,134.00373,913.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Kimberly GentileSVP, Clinical OperationsBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27Declan DooganDirectorSell18,270.0045.25826,717.50375,813.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy16,250.0032.42526,825.0038,810.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsBuy3,935.000.612,400.353,935.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27Declan DooganDirectorSell6,875.0044.17303,668.75394,083.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26Declan DooganDirectorSell100.0044.814,481.00400,958.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26Declan DooganDirectorSell20,796.0044.31921,470.76401,058.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy400.005.602,240.004,039.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09ERIC AGUIARDirectorBuy4,072.0020.7984,656.884,072.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell53,762.0053.432,872,449.904,129.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25Declan DooganDirectorSell100.0045.744,574.00421,854.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25Declan DooganDirectorSell20,334.0045.25920,113.50421,954.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsBuy600.005.603,360.004,239.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell15,783.0050.03789,623.49440,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell16,050.0044.97721,768.50442,288.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10James EngelhartChief Financial OfficerSell300.0068.0720,420.014,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11James EngelhartChief Financial OfficerSell2,452.0064.85159,015.394,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell8,262.0050.02413,265.24455,783.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell5,575.0044.11245,913.25458,338.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtBuy4,296.000.612,620.564,637.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell25,955.0050.151,301,643.25464,045.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell16,110.0050.02805,822.20475,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10James EngelhartChief Financial OfficerSell24,832.0067.531,676,989.394,822.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell7,883.0050.02394,307.66491,110.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell26,007.0050.151,304,251.05498,993.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10John TiltonChief Commercial OfficerBuy52,000.009.29483,080.0052,770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell67,450.0052.953,571,349.3557,891.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy25,000.005.60140,000.0058,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtBuy58,404.000.6135,626.4458,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell15,781.0076.421,205,938.266,097.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy25,000.005.60140,000.0061,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18James EngelhartChief Financial OfficerBuy3,700.006,200.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18Robert BermanSpecial Projects & Med OvrsghtBuy625.00625.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16Declan DooganDirectorSell300.0069.4220,825.01626,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16Declan DooganDirectorSell25,208.0068.731,732,457.61626,302.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell3,488.0054.89191,462.25641.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16Declan DooganDirectorSell31,920.0067.902,167,514.83651,510.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20ERIC AGUIARDirectorBuy6,729.0032.42218,154.186,729.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16Declan DooganDirectorSell2,572.0066.94172,161.71683,430.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell15,797.0068.101,075,800.98686,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11James EngelhartChief Financial OfficerSell6,501.0064.31418,057.866,974.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Charles ConwayChief Scientific OfficerBuy3,000.007,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15Declan DooganDirectorSell18,703.0067.511,262,557.24701,799.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell24,690.0076.021,876,872.087,065.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15Declan DooganDirectorSell34,336.0066.052,267,872.20720,502.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell11,164.0065.62732,560.47754,838.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12Declan DooganDirectorSell25,914.0065.781,704,749.90766,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell2,467.0069.40171,201.91770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12Declan DooganDirectorSell28,086.0064.791,819,683.51791,916.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15Elyse StockChief Medical OfficerBuy800.0010.828,656.00800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12Declan DooganDirectorSell18,400.0063.901,175,767.36820,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12Declan DooganDirectorSell7,600.0062.93478,252.04838,402.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell25,039.0064.571,616,873.39846,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell22,838.0067.531,542,234.158,568.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11Declan DooganDirectorSell18,474.0063.791,178,530.36871,041.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell20,043.0062.781,258,207.34889,515.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell16,444.0061.971,018,988.64909,558.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16Declan DooganDirectorSell50,000.0061.923,096,000.00926,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08Elyse StockChief Medical OfficerBuy937.0055.9152,387.67937.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12Declan DooganDirectorSell38,825.0053.922,093,444.00976,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm